Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
Sponsor: Hoffmann-La Roche
Diffuse Large B-cell Lymphoma
United States, Australia, Belgium, China, Denmark +8 more
- A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 DiabetesActive Not Recruiting
Sponsor: Hoffmann-La Roche
Type 2 Diabetes Mellitus
United States, Hungary, Poland, Spain
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Heart Failure
France
Sponsor: University of Edinburgh
Myocardial Infarction
United Kingdom
- A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous NephropathyActive Not Recruiting
Sponsor: Hoffmann-La Roche
Primary Membranous Nephropathy
United States, Argentina, Brazil, China, France +6 more
- A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration · Diabetic Macular Edema
Austria, Bulgaria, Czechia, Finland, Greece +10 more
- An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's LymphomaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Hodgkins Lymphoma
Belgium, Denmark, Israel, Italy, Spain +1 more
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Canada, Italy, New Zealand, Poland +1 more
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis · Primary Progressive Multiple Sclerosis
China
- An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Neoplasms
China
- A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
China
- Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled TrialNot Yet Recruiting
Sponsor: Singapore National Eye Centre
Central Serous Chorioretinopathy (CSC)
Sponsor: Hoffmann-La Roche
Diffuse Large B-Cell Lymphoma
China
Sponsor: Cancer Research UK
Haematological Malignancy · Solid Tumour
United Kingdom
Sponsor: University Hospital, Brest
Non-small Cell Lung Cancer
France
Sponsor: French Innovative Leukemia Organisation
Richter Syndrome
France
Sponsor: Hoffmann-La Roche
Asthma
United States, Argentina, Brazil, Canada, Colombia +16 more
- A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Small-Cell Lung Cancer
United States, Belgium, Germany, Greece, Hungary +8 more
- Fenofibrate for Prevention of DR WorseningActive Not Recruiting
Sponsor: Jaeb Center for Health Research
Diabetic Retinopathy
United States
- HAIQU (Hospital AIr QUality)Not Yet Recruiting
Sponsor: Mayo Clinic
Acute Respiratory Tract Infection
United States
Sponsor: Nantes University Hospital
Bacterial Infection
France
Sponsor: Sarepta Therapeutics, Inc.
Duchenne Muscular Dystrophy
United States
- Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell LymphomaActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Lymphoma, B-Cell
Canada
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +14 more
- A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes MellitusActive Not Recruiting
Sponsor: Carmot Therapeutics, Inc.
Overweight or Obese · Type 2 Diabetes Mellitus (T2DM)
United States, Argentina, Canada, Mexico, New Zealand +1 more